The second call for new Proof of Concept (PoC) projects is now open
Masaryk University accepts PoC projects focused on supporting the application potential of science and research.
CTT MU Participated in Prague.bio Conference 2025
On Thursday, September 25, the third edition of the Prague.bio Conference 2025 took place in Prague, bringing together over 400 participants from around the world. The Technology Transfer Centre of Masaryk University attended the conference, and PhD student Isar Mohd from CEITEC MU delivered a pitch presenting the RNAutrix – A Platform for RNA-based Drug Screening and Beyond, a modern platform for RNA-based drug screening, opening new possibilities for the development of RNA therapeutics.
The event focused on innovations in drug development, diagnostics, medical technologies, artificial intelligence applications, and technology transfer, as well as legal and investment aspects of research and commercialization. The program included a startup pitch session, panel discussions, networking opportunities, and the possibility for B2B meetings via a dedicated platform. For the first time, the conference featured four specialized workshops, allowing participants to discuss current topics in biotechnology and technology transfer in more depth.
PhD student Isar Mohd’s pitch showcased RNAutrix, a modern platform for RNA-based drug screening. It enables the efficient identification of small molecules that bind to specific RNA sequences and opens new opportunities for developing RNA therapeutics in areas such as oncology, neurology, and infectious diseases.
Attending the Prague.bio Conference gave CTT MU the opportunity to follow current trends in biotechnology, establish contacts with partners from academia and industry, and support the transfer of technologies developed at Masaryk University.
Article about Prague.bio Conference 2025
